Notice of Participation of the Office of Research on Women's Health (ORWH) in RFA-DA-19-029, HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34 Clinical Trial Not Allowed) and RFA-DA-19-036, HEAL Initiative: HEA

Notice Number: NOT-OD-19-063

Key Dates
Release Date: January 22, 2019

Related Announcements

RFA-DA-19-029
RFA-DA-19-036


Issued by
Office of Research on Women’s Health (
ORWH)

Purpose

The purpose of this notice is to inform potential applicants that the Office of Research on Women’s Health (ORWH) will participate, effective immediately, in two FOAs: (1) RFA-DA-19-029, HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34 Clinical Trial Not Allowed) and (2) RFA-DA-19-036, HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (R34 Clinical Trial Not Allowed)

Part 1. Overview Information

The following information has been added.

Components of Participating Organizations

Office of Research on Women’s Health (ORWH)

Catalog of Federal Domestic Assistance (CFDA) Number(s):

93.313

Part 2. Section I. Funding Opportunity Description

Research Objectives:

The following information has been added:

Specific Areas of Research Interest for ORWH: The Office of Research on Women’s Health (ORWH) is part of the Office of the Director of NIH and works in partnership with the 27 NIH Institutes and Centers to ensure that women's health research is part of the scientific framework at the NIH and throughout the scientific community. Given the higher prevalence of pain disorders in females and their greater sensitivity to pain, there is a crucial need to include women in pain and opioid-related research. Integrating the purposeful accounting for sex as a biological variable (SABV) in biomedical research on pain and opioid use throughout the life span will fill gaps in our knowledge and inform more effective, personalized approaches to improve heath for women and men. For additional guidance, the 2019-2023 Trans-NIH Strategic Plan for the Health of Women covering is available on the ORWH website (https://www.nih.gov/women/strategicplan) for additional guidance.

Part 2. Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s):

Rebecca DelCarmen Wiggins, Ph.D.

Office of Research on Women’s Health (ORWH)
Telephone: 301-451-8689

Email: rdelcarm@nih.gov

All other aspects of these FOAs remain the same.

Inquiries

Please direct all inquiries to:

Rebecca DelCarmen Wiggins, Ph.D.
Office of Research on Women’s Health (ORWH)
Telephone: 301-451-8689
Email: rdelcarm@nih.gov